• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐碳青霉烯类肺炎克雷伯菌的出现:心脏外科病房的逐步传播及四年观察期

Emergence of Carbapenem-Resistant Klebsiella pneumoniae: Progressive Spread and Four-Year Period of Observation in a Cardiac Surgery Division.

作者信息

Lombardi Fortunata, Gaia Paola, Valaperta Rea, Cornetta Maria, Tejada Milvana Rosa, Di Girolamo Luca, Moroni Alessandra, Ramundo Federica, Colombo Alessio, Valisi Massimiliano, Costa Elena

机构信息

Research Laboratories-Molecular Biology, IRCCS Policlinico San Donato, San Donato Milanese, 20097 Milan, Italy.

Clinical Microbiology Laboratory, IRCCS Policlinico San Donato, Milan, Italy.

出版信息

Biomed Res Int. 2015;2015:871947. doi: 10.1155/2015/871947. Epub 2015 May 4.

DOI:10.1155/2015/871947
PMID:26064962
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4434196/
Abstract

Frequent use of carbapenems has contributed to the increase to K. pneumoniae strains resistant to this class of antibiotics (CRKP), causing a problem in the clinical treatment of patients. This investigation reports the epidemiology, genetic diversity, and clinical implication of the resistance to drugs mediated by CRKP in our hospital. A total of 280 K. pneumoniae strains were collected; in particular 98/280 (35%) were CRKP. Sequencing analysis of CRKP isolated strains showed that 9/98 of MBL-producing strains carried the bla VIM-1 gene and 89/98 of the isolates were positive for bla KPC-2. Antimicrobial susceptibility tests revealed a complete resistance to third-generation cephalosporins and a moderate resistance to tigecycline, gentamicin, and fluoroquinolones with percentages of resistance of 61%, 64%, and 98%, respectively. A resistance of 31% was shown towards trimethoprim-sulfamethoxazole. Colistin was the most active agent against CRKP with 99% of susceptibility. Clonality was evaluated by PFGE and MLST: MLST showed the same clonal type, ST258, while PFGE analysis indicated the presence of a major clone, namely, pulsotype A. This finding indicates that the prevalent resistant isolates were genetically related, suggesting that the spread of these genes could be due to clonal dissemination as well as to genetic exchange between different clones.

摘要

碳青霉烯类药物的频繁使用导致了耐碳青霉烯类肺炎克雷伯菌(CRKP)菌株的增加,给患者的临床治疗带来了问题。本调查报道了我院CRKP介导的耐药性的流行病学、遗传多样性及临床意义。共收集了280株肺炎克雷伯菌菌株;其中98/280(35%)为CRKP。对CRKP分离菌株的测序分析表明,9/98产金属β-内酰胺酶(MBL)的菌株携带bla VIM-1基因,89/98的分离株bla KPC-2呈阳性。药敏试验显示对第三代头孢菌素完全耐药,对替加环素、庆大霉素和氟喹诺酮类药物中度耐药,耐药率分别为61%、64%和98%。对复方新诺明的耐药率为31%。黏菌素是对CRKP活性最强的药物,敏感性为99%。通过脉冲场凝胶电泳(PFGE)和多位点序列分型(MLST)评估克隆性:MLST显示为同一克隆型ST258,而PFGE分析表明存在一个主要克隆,即脉冲型A。这一发现表明流行的耐药菌株具有遗传相关性,提示这些基因的传播可能是由于克隆传播以及不同克隆之间的基因交换。

相似文献

1
Emergence of Carbapenem-Resistant Klebsiella pneumoniae: Progressive Spread and Four-Year Period of Observation in a Cardiac Surgery Division.耐碳青霉烯类肺炎克雷伯菌的出现:心脏外科病房的逐步传播及四年观察期
Biomed Res Int. 2015;2015:871947. doi: 10.1155/2015/871947. Epub 2015 May 4.
2
Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d'Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789).意大利瓦莱达奥斯塔地区耐碳青霉烯类肠杆菌科的分子流行病学研究显示,产 KPC-2 的肺炎克雷伯菌克隆复合体 101(ST101 和 ST1789)的出现。
BMC Microbiol. 2015 Nov 9;15(1):260. doi: 10.1186/s12866-015-0597-z.
3
Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns.肺炎克雷伯菌分离株中的碳青霉烯类耐药性:危险因素、分子特征及药敏模式
Infect Control Hosp Epidemiol. 2009 Jul;30(7):666-71. doi: 10.1086/598244.
4
Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand.泰国一家大学医院耐碳青霉烯类肠杆菌科细菌的基因特征及耐碳青霉烯类肺炎克雷伯菌ST340的传播
PLoS One. 2015 Sep 25;10(9):e0139116. doi: 10.1371/journal.pone.0139116. eCollection 2015.
5
Molecular Epidemiology and Drug Resistance Pattern of Carbapenem-Resistant Klebsiella pneumoniae Isolates from Iran.伊朗碳青霉烯类耐药肺炎克雷伯菌分离株的分子流行病学及耐药模式
Microb Drug Resist. 2019 Apr;25(3):336-343. doi: 10.1089/mdr.2017.0404. Epub 2018 Oct 23.
6
[Preliminary study on resistance mechanism and virulence features in carbapenems-resistant from burn patients].烧伤患者碳青霉烯类耐药菌耐药机制及毒力特征的初步研究
Zhonghua Shao Shang Za Zhi. 2018 Nov 20;34(11):796-801. doi: 10.3760/cma.j.issn.1009-2587.2018.11.015.
7
An Update of the Evolving Epidemic of blaKPC Carrying Klebsiella pneumoniae in Sicily, Italy, 2014: Emergence of Multiple Non-ST258 Clones.2014年意大利西西里岛携带blaKPC的肺炎克雷伯菌流行情况的最新进展:多种非ST258克隆株的出现
PLoS One. 2015 Jul 15;10(7):e0132936. doi: 10.1371/journal.pone.0132936. eCollection 2015.
8
[Epidemiology investigation of carbapenems-resistant in burn care unit].[烧伤护理单元碳青霉烯类耐药菌的流行病学调查]
Zhonghua Shao Shang Za Zhi. 2019 Nov 20;35(11):798-803. doi: 10.3760/cma.j.issn.1009-2587.2019.11.006.
9
Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.产KPC-2碳青霉烯酶肺炎克雷伯菌菌株在希腊的克隆传播。
J Antimicrob Chemother. 2009 Aug;64(2):348-52. doi: 10.1093/jac/dkp207. Epub 2009 Jun 13.
10
The plasmid-mediated fosfomycin resistance determinants and synergy of fosfomycin and meropenem in carbapenem-resistant Klebsiella pneumoniae isolates in Taiwan.台湾碳青霉烯类耐药肺炎克雷伯菌分离株中介导磷霉素耐药的质粒决定因子和磷霉素与美罗培南的协同作用。
J Microbiol Immunol Infect. 2017 Oct;50(5):653-661. doi: 10.1016/j.jmii.2017.03.003. Epub 2017 Jun 28.

引用本文的文献

1
The Global and Regional Prevalence of Hospital-Acquired Carbapenem-Resistant Infection: A Systematic Review and Meta-analysis.医院获得性耐碳青霉烯类感染的全球及区域患病率:一项系统评价与荟萃分析
Open Forum Infect Dis. 2023 Dec 19;11(2):ofad649. doi: 10.1093/ofid/ofad649. eCollection 2024 Feb.
2
Clinical carbapenem-resistant isolates simultaneously harboring , types and qnrS genes from the Kingdom of Bahrain: Resistance profile and genetic environment.来自巴林王国的同时携带 、 和 qnrS 基因的临床耐碳青霉烯 分离株:耐药谱和遗传环境。
Front Cell Infect Microbiol. 2022 Oct 11;12:1033305. doi: 10.3389/fcimb.2022.1033305. eCollection 2022.
3

本文引用的文献

1
Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches.多重耐药和广泛耐药革兰氏阴性病原体:当前及新出现的治疗方法
Expert Opin Pharmacother. 2014 Jul;15(10):1351-70. doi: 10.1517/14656566.2014.914172. Epub 2014 Apr 28.
2
Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: a case-case-control study.耐碳青霉烯类肺炎克雷伯菌感染/定植的危险因素:一项病例-病例对照研究。
J Infect Chemother. 2014 May;20(5):293-7. doi: 10.1016/j.jiac.2013.11.007. Epub 2014 Apr 3.
3
Molecular characterization of carbapenem-resistant strains of Klebsiella pneumoniae isolated from Iranian patients: first identification of blaKPC gene in Iran.
In Vitro Investigation of the Impact of Bacterial-Fungal Interaction on Carbapenem-Resistant .
体外研究细菌-真菌相互作用对碳青霉烯类耐药. 的影响
Molecules. 2022 Apr 14;27(8):2541. doi: 10.3390/molecules27082541.
4
Inhibition of the Quorum Sensing System, Elastase Production and Biofilm Formation in by Psammaplin A and Bisaprasin.Psammaplin A 和 Bisaprasin 抑制 中的群体感应系统、弹性蛋白酶产生和生物膜形成。
Molecules. 2022 Mar 6;27(5):1721. doi: 10.3390/molecules27051721.
5
Prevalence of Carbapenem-Resistant Infection in a Northern Province in China: Clinical Characteristics, Drug Resistance, and Geographic Distribution.中国北方某省耐碳青霉烯类感染的患病率:临床特征、耐药性及地理分布
Infect Drug Resist. 2022 Feb 22;15:569-579. doi: 10.2147/IDR.S347343. eCollection 2022.
6
Risk Factors Affecting Clinical Outcome in Patients with Carbapenem-Resistant K. pneumoniae: A Retrospective Study.碳青霉烯类耐药肺炎克雷伯菌感染患者临床结局的影响因素:一项回顾性研究。
Med Sci Monit. 2020 Oct 24;26:e925693. doi: 10.12659/MSM.925693.
7
Molecular characterization of class 1, 2 and 3 integrons in clinical multi-drug resistant isolates.临床多药耐药分离株中 1、2 和 3 类整合子的分子特征。
Antimicrob Resist Infect Control. 2019 Mar 29;8:59. doi: 10.1186/s13756-019-0509-3. eCollection 2019.
8
The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant .甲氧苄啶/磺胺甲恶唑在治疗耐碳青霉烯类药物引起的感染中的作用
Open Forum Infect Dis. 2018 Dec 14;6(1):ofy351. doi: 10.1093/ofid/ofy351. eCollection 2019 Jan.
9
Intensive care antibiotic consumption and resistance patterns: a cross-correlation analysis.重症监护抗生素消耗与耐药模式:交叉相关分析。
Ann Clin Microbiol Antimicrob. 2017 Nov 13;16(1):71. doi: 10.1186/s12941-017-0251-8.
10
Trimethoprim-sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series.针对产碳青霉烯酶肺炎克雷伯菌感染患者的甲氧苄啶-磺胺甲恶唑治疗:回顾性单中心病例系列研究
Infection. 2017 Apr;45(2):209-213. doi: 10.1007/s15010-016-0968-x. Epub 2017 Feb 9.
从伊朗患者中分离出的耐碳青霉烯肺炎克雷伯菌菌株的分子特征:伊朗首次鉴定出blaKPC基因
Microb Drug Resist. 2014 Aug;20(4):285-93. doi: 10.1089/mdr.2013.0074. Epub 2014 Jan 15.
4
Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.通过体外时间杀菌实验评估用于产VIM和NDM的肺炎克雷伯菌的双联和三联抗生素组合。
Antimicrob Agents Chemother. 2014;58(3):1757-62. doi: 10.1128/AAC.00741-13. Epub 2014 Jan 6.
5
Combination therapy for carbapenem-resistant Gram-negative bacteria.碳青霉烯类耐药革兰氏阴性菌的联合治疗。
Expert Rev Anti Infect Ther. 2013 Dec;11(12):1333-53. doi: 10.1586/14787210.2013.845523. Epub 2013 Nov 6.
6
Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence.碳青霉烯类耐药肠杆菌科细菌感染的抗生素治疗:现有证据的系统评价。
Antimicrob Agents Chemother. 2014;58(2):654-63. doi: 10.1128/AAC.01222-13. Epub 2013 Sep 30.
7
KPC - 3 Klebsiella pneumoniae ST258 clone infection in postoperative abdominal surgery patients in an intensive care setting: analysis of a case series of 30 patients.术后腹部手术患者重症监护环境中感染产碳青霉烯酶肺炎克雷伯菌 ST258 克隆(KPC-3):30 例患者的病例系列分析。
BMC Anesthesiol. 2013 Jul 3;13(1):13. doi: 10.1186/1471-2253-13-13.
8
Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae.多黏菌素联合利福平对产碳青霉烯酶肺炎克雷伯菌的协同作用。
Antimicrob Agents Chemother. 2013 Aug;57(8):3990-3. doi: 10.1128/AAC.00179-13. Epub 2013 Jun 10.
9
Polymyxins and Doripenem Combination Against KPC-Producing Klebsiella pneumoniae.多粘菌素与多黏菌素联合治疗产KPC肺炎克雷伯菌感染
J Clin Med Res. 2013 Apr;5(2):97-100. doi: 10.4021/jocmr1220w. Epub 2013 Feb 25.
10
Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010.与医疗保健相关感染相关的抗微生物药物耐药病原体:2009-2010 年向疾病预防控制中心国家医疗保健安全网络报告的数据摘要。
Infect Control Hosp Epidemiol. 2013 Jan;34(1):1-14. doi: 10.1086/668770. Epub 2012 Nov 27.